79 related articles for article (PubMed ID: 12574801)
1. Effect of factor VIII on tissue factor-initiated spatial clot growth.
Ovanesov MV; Lopatina EG; Saenko EL; Ananyeva NM; Ul'yanova LI; Plyushch OP; Butilin AA; Ataullakhanov FI
Thromb Haemost; 2003 Feb; 89(2):235-42. PubMed ID: 12574801
[TBL] [Abstract][Full Text] [Related]
2. Drug-drug interaction of the anti-TFPI aptamer BAX499 and factor VIII: studies of spatial dynamics of fibrin clot formation in hemophilia A.
Parunov LA; Soshitova NP; Fadeeva OA; Balandina AN; Kopylov KG; Kumskova MA; Gilbert JC; Schaub RG; McGinness KE; Ataullakhanov FI; Panteleev MA
Thromb Res; 2014 Jan; 133(1):112-9. PubMed ID: 24263002
[TBL] [Abstract][Full Text] [Related]
3. Hemophilia A and B are associated with abnormal spatial dynamics of clot growth.
Ovanesov MV; Krasotkina JV; Ul'yanova LI; Abushinova KV; Plyushch OP; Domogatskii SP; Vorob'ev AI; Ataullakhanov FI
Biochim Biophys Acta; 2002 Aug; 1572(1):45-57. PubMed ID: 12204332
[TBL] [Abstract][Full Text] [Related]
4. Initiation and propagation of coagulation from tissue factor-bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rate.
Ovanesov MV; Ananyeva NM; Panteleev MA; Ataullakhanov FI; Saenko EL
J Thromb Haemost; 2005 Feb; 3(2):321-31. PubMed ID: 15670039
[TBL] [Abstract][Full Text] [Related]
5. Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively.
Panteleev MA; Ovanesov MV; Kireev DA; Shibeko AM; Sinauridze EI; Ananyeva NM; Butylin AA; Saenko EL; Ataullakhanov FI
Biophys J; 2006 Mar; 90(5):1489-500. PubMed ID: 16326897
[TBL] [Abstract][Full Text] [Related]
6. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
Mosnier LO; Lisman T; van den Berg HM; Nieuwenhuis HK; Meijers JC; Bouma BN
Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321
[TBL] [Abstract][Full Text] [Related]
7. A putative inhibitory mechanism in the tenase complex responsible for loss of coagulation function in acquired haemophilia A patients with anti-C2 autoantibodies.
Matsumoto T; Nogami K; Ogiwara K; Shima M
Thromb Haemost; 2012 Feb; 107(2):288-301. PubMed ID: 22234708
[TBL] [Abstract][Full Text] [Related]
8. Coagulation potential of immobilised factor VIII in flow-dependent fibrin generation on platelet surfaces.
Doi M; Sugimoto M; Matsui H; Matsunari Y; Shima M
Thromb Haemost; 2013 Aug; 110(2):316-22. PubMed ID: 23636463
[TBL] [Abstract][Full Text] [Related]
9. Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow.
Swieringa F; Kuijpers MJ; Lamers MM; van der Meijden PE; Heemskerk JW
Haematologica; 2015 Jun; 100(6):748-56. PubMed ID: 25769543
[TBL] [Abstract][Full Text] [Related]
10. The binding sites for the very low density lipoprotein receptor and low-density lipoprotein receptor-related protein are shared within coagulation factor VIII.
Ananyeva NM; Makogonenko YM; Kouiavskaia DV; Ruiz J; Limburg V; Meijer AB; Khrenov AV; Shima M; Strickland DK; Saenko EL
Blood Coagul Fibrinolysis; 2008 Mar; 19(2):166-77. PubMed ID: 18277139
[TBL] [Abstract][Full Text] [Related]
11. Influence of factor VIII on overall coagulability and fibrinolytic potential of haemophilic plasma as measured by global assay: monitoring in haemophilia A.
Goldenberg NA; Hathaway WE; Jacobson L; McFarland K; Manco-Johnson MJ
Haemophilia; 2006 Nov; 12(6):605-14. PubMed ID: 17083510
[TBL] [Abstract][Full Text] [Related]
12. The disappearing act of factor VIII.
Lenting PJ; Christophe OD; Guéguen P
Haemophilia; 2010 May; 16(102):6-15. PubMed ID: 18771423
[TBL] [Abstract][Full Text] [Related]
13. Measurement of global haemostasis in severe haemophilia A following factor VIII infusion.
Lewis SJ; Stephens E; Florou G; Macartney NJ; Hathaway LS; Knipping J; Collins PW
Br J Haematol; 2007 Sep; 138(6):775-82. PubMed ID: 17672884
[TBL] [Abstract][Full Text] [Related]
14. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
von dem Borne PA; Cox LM; Bouma BN
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
[TBL] [Abstract][Full Text] [Related]
15. Clot waveform analysis in patients with haemophilia A.
Siegemund T; Scholz U; Schobess R; Siegemund A
Hamostaseologie; 2014; 34 Suppl 1():S48-52. PubMed ID: 25382770
[TBL] [Abstract][Full Text] [Related]
16. High dose factor VIIa improves clot structure and stability in a model of haemophilia B.
Wolberg AS; Allen GA; Monroe DM; Hedner U; Roberts HR; Hoffman M
Br J Haematol; 2005 Dec; 131(5):645-55. PubMed ID: 16351642
[TBL] [Abstract][Full Text] [Related]
17. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
Mosnier LO; von dem Borne PA; Meijers JC; Bouma BN
Thromb Haemost; 1998 Nov; 80(5):829-35. PubMed ID: 9843179
[TBL] [Abstract][Full Text] [Related]
18. Role of fibrinogen-, factor VIII- and XIII-mediated clot propagation in gelatin haemodilution.
Schramko AA; Kuitunen AH; Suojaranta-Ylinen RT; Niemi TT
Acta Anaesthesiol Scand; 2009 Jul; 53(6):731-5. PubMed ID: 19239406
[TBL] [Abstract][Full Text] [Related]
19. Physical and chemical properties of normal and haemophilic factor VIII.
Vermylen J
Pathol Biol (Paris); 1975 Dec; 23 suppl():5-10. PubMed ID: 772559
[TBL] [Abstract][Full Text] [Related]
20. Factor VIII efficient and specific non-covalent binding to PEGylated liposomes enables prolongation of its circulation time and haemostatic efficacy.
Baru M; Carmel-Goren L; Barenholz Y; Dayan I; Ostropolets S; Slepoy I; Gvirtzer N; Fukson V; Spira J
Thromb Haemost; 2005 Jun; 93(6):1061-8. PubMed ID: 15968389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
